Home / Centerstage / 2019 / june / Week 4 /
AbbVie announces its plan to acquire Allergan for about $63 billion, expanding its pharmaceutical portfolio. The deal combines AbbVie's expertise in drugs like Humira with Allergan's Botox and other aesthetics products, aiming to create a diversified healthcare company.
Monday, 24 June, 2019